AmerisourceBergen Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen or view top-rated stocks.

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

AmerisourceBergen saw a decline in short interest in August. As of August 13th, there was short interest totaling 1,540,000 shares, a decline of 25.6% from the July 29th total of 2,070,000 shares. Based on an average trading volume of 886,300 shares, the short-interest ratio is presently 1.7 days. Currently, 1.0% of the shares of the company are sold short.
View AmerisourceBergen's Short Interest.

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for AmerisourceBergen.

AmerisourceBergen Co. (NYSE:ABC) posted its quarterly earnings data on Tuesday, August, 3rd. The company reported $2.16 EPS for the quarter, beating the Zacks' consensus estimate of $2.04 by $0.12. The company had revenue of $53.41 billion for the quarter, compared to analyst estimates of $52.62 billion. AmerisourceBergen had a negative net margin of 1.83% and a negative trailing twelve-month return on equity of 694.83%. The firm's quarterly revenue was up 17.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.85 EPS.
View AmerisourceBergen's earnings history.

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABC stock has increased by 45.3% and is now trading at $123.47.
View which stocks have been most impacted by COVID-19.

AmerisourceBergen announced a quarterly dividend on Wednesday, August 4th. Investors of record on Monday, August 16th will be given a dividend of $0.44 per share on Tuesday, September 7th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, August 13th.
View AmerisourceBergen's dividend history.

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.42%. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 16.57% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

AmerisourceBergen updated its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided earnings per share (EPS) guidance of $9.150-$9.300 for the period, compared to the Thomson Reuters consensus estimate of $9.030. The company issued revenue guidance of -.

10 brokerages have issued twelve-month price targets for AmerisourceBergen's shares. Their forecasts range from $114.00 to $162.00. On average, they expect AmerisourceBergen's stock price to reach $137.00 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view top-rated stocks among Wall Street analysts.

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of ABC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.24%), BlackRock Inc. (5.55%), JPMorgan Chase & Co. (3.85%), State Street Corp (3.13%), Boston Partners (2.29%) and FMR LLC (1.78%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

ABC stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Royal Bank of Canada, BlackRock Inc., Lazard Asset Management LLC, AQR Capital Management LLC, Renaissance Technologies LLC, Bank of New York Mellon Corp, and Boston Partners. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, Silvana Battaglia, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

ABC stock was acquired by a variety of institutional investors in the last quarter, including Amundi, JPMorgan Chase & Co., Schonfeld Strategic Advisors LLC, PNC Financial Services Group Inc., Neuberger Berman Group LLC, TimesSquare Capital Management LLC, APG Asset Management N.V., and Scout Investments Inc..
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ABC stock can currently be purchased for approximately $123.47.

AmerisourceBergen has a market capitalization of $25.66 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis.

AmerisourceBergen employs 22,000 workers across the globe.

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

AmerisourceBergen was founded in 2001.

The official website for AmerisourceBergen is www.amerisourcebergen.com.

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at (610) 727-7000 or via email at [email protected]